Washington DC, February 6, 2009 - The American Association for Clinical Chemistry (AACC) and the United Kingdom’s Association for Clinical Biochemistry (ACB) announce a 11/2-day conference on the Latest Advances in Chronic Disease to be held May 6-7, 2009 at the Hyatt Regency Hotel, Newport Beach, CA. The UK element of the conference will be held September 3-4, 2009 at the Royal College of Pathologists in London, UK. For more information, visit the ACB Meetings Section.
Chronic disease represents an increasing public health problem in the US. According to the Centers for Disease Control & Prevention (CDC), more than 870,000 people in the US die of heart disease and stroke every year (that is around 2,400 people per day) and 23.6 million people, almost 8% of the population, have diabetes. It is estimated that 27 million Americans have over- or underactive thyroid glands although more than 50% remain undiagnosed. More than 80% of patients suffering from thyroid disease are women. Women are five to eight times more likely than men to suffer from hypothyroidism (underactive thyroid) and 15 – 20% of people with diabetes are likely to develop thyroid disease, compared to 4.5% of the general population.
The conference faculty, drawn from the US and UK, will cover key issues including new American Diabetes Association recommendations, emerging markers for cardiac risk, hemoglobin A1c’s role in diagnosing diabetes, whether or not to treat subclinical hypothyroidism, and what can be learned from the UK perspective. The conference will conclude with a discussion of physiological age vs. chronological age, and the role of the lab and the impact on testing recommendations. Follow the link for a complete conference program.
AACC invites the press to attend the conference at no charge. To register, complete and submit the Press Registration Form. If you have any questions about the conference or AACC, please contact Peter Patterson on the telephone numbers above.
The program is presented jointly by the American Association for Clinical Chemistry and the Association for Clinical Biochemistry and is supported by Beckman Coulter, Inc., Roche Diagnostics, and Siemens Healthcare Diagnostics.